The Fetal Medicine Foundation 20th World Congress in Fetal Medicine, Valencia, Spain
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • Brain
    • Face
    • Heart
    • Lungs
    • Gastrointestinal
    • Abdominal wall
    • Genitourinary
    • Spine
    • Skeleton
    • Hydrops
    • Placenta
    • Other
  • Genetics
    • Exome sequencing
    • Other
  • Artificial placenta
  • Fetal therapy
  • Fetal anemia
  • Congenital infection
    • CMV
    • COVID 19
    • Other
  • Maternal medicine
  • Preeclampsia
  • Gestational diabetes
  • Growth
  • Preterm birth
  • Obstetrics
  • Twins
    • TTTS
    • sFGR
    • TRAP
    • Other
  • Miscellaneous

cfDNA test

  1. Benefits of the cell-free fetal DNA protocol for the screening of prenatal aneuploidies View pdf
  2. Cell-free DNA screening in singleton and twin pregnancies: three years of clinical experience View pdf
  3. Cf DNA for Monosomy X and X chromosome variants in relation to ultrasound findings View pdf
  4. CfDNA testing for diagnosis of sickle cell disease: meta-analysis View pdf
  5. Efficacy of cf DNA test as a screening method View pdf
  6. Efficacy of contingent aneuploidy test View pdf
  7. Experience in use of non-invasive prenatal testing View pdf
  8. Rapid non-invasive prenatal screening test for trisomy 21 based on digital droplet PCR View pdf
  9. Revolutionizing cfDNA testing with self-collected capillary blood samples View pdf
  10. Role of second trimester ultrasound isolated soft markers in the era of fetal cell-free DNA View pdf
4585455247744853471347194388442845984824
© 2023 The Fetal Medicine Foundation